SCHEMBL1669438

SCHEMBL1669438

O=C(N/N=C/c1cc(Br)c(O)c(Br)c1)c1ccc(-c2ccccc2)c(F)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.60
MEN1 O00255 5/20 0.58
KMT2A Q03164 5/20 0.58
LMNA P02545 1/20 0.58
MAPT P10636 1/20 0.58
SIRT1 Q96EB6 7/20 0.55
CHEK1 O14757 1/20 0.53
AURKA O14965 1/20 0.53
DAPK3 O43293 1/20 0.53
JAK2 O60674 1/20 0.53
PRKD3 O94806 1/20 0.53
MAP4K4 O95819 1/20 0.53
PAK4 O96013 1/20 0.53
ABL1 P00519 1/20 0.53
NTRK1 P04629 1/20 0.53
LCK P06239 1/20 0.53
CSF1R P07333 1/20 0.53
RET P07949 1/20 0.53
IGF1R P08069 1/20 0.53
MET P08581 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3631618 0.88 POLB (0.61) POLBMEN1KMT2ALMNAMAPT
SCHEMBL3631622 0.88 POLB (0.61) POLBMEN1KMT2ALMNAMAPT
SCHEMBL1669408 0.85 POLB (0.79) POLBMEN1KMT2ALMNAMAPT
SCHEMBL1669410 0.85 POLB (0.79) POLBMEN1KMT2ALMNAMAPT
SCHEMBL10026668 0.81 RAB9A (0.56) POLBMEN1KMT2AMAPTRAB9A
SCHEMBL1669357 0.79 SIRT1 (0.74) POLBMEN1KMT2ALMNAMAPT
SCHEMBL1669361 0.79 SIRT1 (0.74) POLBMEN1KMT2ALMNAMAPT
SCHEMBL1669490 0.78 MEN1 (0.67) POLBMEN1KMT2ALMNAMAPT
SCHEMBL1669488 0.78 MEN1 (0.67) POLBMEN1KMT2ALMNAMAPT
SCHEMBL1672436 0.77 POLB (0.64) POLBMEN1KMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2490696-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISORDERS OF GLUCOSE HOMEOSTASIS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2012-08-29 EP disclosed
WO-2011048070-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISORDERS OF GLUCOSE HOMEOSTASIS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2011-04-28 WO disclosed